Scarica l'app Stockscreener
6.24
54.07%
2.19
Dopo l'orario di chiusura:
5.91
-0.33
-5.29%
Precedente Chiudi:
$4.05
Aprire:
$6.3
Volume 24 ore:
83.49M
Relative Volume:
60.19
Capitalizzazione di mercato:
$11.73M
Reddito:
$15.66M
Utile/perdita netta:
$5.83M
Rapporto P/E:
-0.2612
EPS:
-23.8939
Flusso di cassa netto:
$466.20K
1 W Prestazione:
-59.79%
1M Prestazione:
-45.50%
6M Prestazione:
+20.23%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$5.66
$8.44
Intervallo di 1 settimana:
$3.75
$17.19
Portata 52W:
$2.90
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Nome
Neuphoria Therapeutics Inc
Settore
Industria
Telefono
781-439-5551
Indirizzo
100 SUMMIT DR, BURLINGTON
Confronta NEUP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
6.24 | 9.55M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Reiterato | Maxim Group | Buy |
| 2022-01-10 | Iniziato | Berenberg | Buy |
| 2022-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Iniziato | Evercore ISI | Outperform |
| 2022-01-10 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Neuphoria Therapeutics Inc Borsa (NEUP) Ultime notizie
Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessTrade Volume Summary & Reliable Price Breakout Alerts - newser.com
Can Neuphoria Therapeutics Inc. stock hit analyst price targetsTrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com
Is Neuphoria Therapeutics Inc. stock attractive after correctionBear Alert & Real-Time Stock Movement Alerts - newser.com
Using AI based signals to follow Neuphoria Therapeutics Inc.2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - newser.com
Neuphoria Therapeutics Inc.’s volatility index tracking explainedPortfolio Profit Report & High Win Rate Trade Alerts - newser.com
How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
Automated trading signals detected on Neuphoria Therapeutics Inc.Trade Volume Summary & Weekly High Return Forecasts - newser.com
Why hedge funds are buying Neuphoria Therapeutics Inc. stockInsider Selling & Stepwise Trade Execution Plans - newser.com
Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsTrade Exit Summary & Weekly High Potential Alerts - newser.com
Best Biotech Stocks To Keep An Eye OnOctober 25th - MarketBeat
Published on: 2025-10-26 10:45:26 - newser.com
Neuphoria Therapeutics Advances BNC-210 Trial with Prolonged Cash Runway - StocksToTrade
Published on: 2025-10-26 11:32:54 - newser.com
Why analysts upgrade Neuphoria Therapeutics Inc. stockTrade Entry Summary & Verified Short-Term Plans - newser.com
Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Published on: 2025-10-25 19:04:06 - newser.com
Neuphoria Therapeutics Stock Gains Amid Phase 3 Trial Advances - StocksToTrade
Neuphoria Therapeutics Advances Social Anxiety Drug in Key Phase 3 Trial - timothysykes.com
Neuphoria Therapeutics Inc Azioni (NEUP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):